{"mainPropery":{"diseaseId":2830,"diseaseName":"Ornithine translocase deficiency syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2830/ornithine-translocase-deficiency-syndrome","synonyms":["Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome","HHH syndrome","HHHS","HHH","Ornithine translocase deficiency"],"synonyms-with-source":[{"name":"Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome"},{"name":"HHH syndrome"},{"name":"HHHS"},{"name":"HHH"},{"name":"Ornithine translocase deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"238970"},{"identifierType":"ORPHANET","identifierId":"415"},{"identifierType":"UMLS","identifierId":"C0268540"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":381,"resourceName":"National Urea Cycle Disorders Foundation","abbreviation":"","address1":"75 South Grand Avenue","address2":"","address3":"","address4":"","address5":"","city":"Pasadena","state":"CA","zip":"91105","country":"United States","phone":"+1-626-578-0833","tty":"","tollFree":"800-38-NUDCF (386-8233)","fax":"","email":"info@nucdf.org","url":"http://www.nucdf.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/238970' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=238970' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Ornithine translocase deficiency syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/ornithine-translocase-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Ornithine translocase deficiency syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":415,"resourceId":1223,"resourceName":"National Urea Cycle Disorder 2011 Conference","descriptionText":"<a href='http://www.nucdf.org/events.htm ' target='_blank'>Reaching for a Cure: 2011 NUCDF Annual Conference</a>, July 8 2011 - July 10, 2011 <br /><strong>Location: </strong>Sheraton Denver Downtown, Denver, Colorado <br /><strong>Description: </strong>This conference offers the unique opportunity to meet other UCD families, stay informed, and learn about new advances in research, treatment and management to improve the lives of children and adults with UCD. Working together, our NUCDF families and community of committed researchers and medical professionals are making a major impact with advances in the understanding of UCDs, accelerating research, and improved outcomes in children and adults with UCD. In the past four years, research for UCDs has increased by 400%! Let's continue the momentum and end the devastating effects of UCD. ","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":725,"resourceId":1420,"resourceName":"RDCRN - Urea Cycle Disorders Consortium Registry","descriptionText":"<p>The <a href='https://www.rarediseasesnetwork.org/cms/ucdc' target='_blank'>Urea Cycle Disorders Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the US, working together to improve the lives of people with Urea Cycle Disorders. The Urea Cycle Disorders Consortium maintains a registry for patients who wish to be contacted about clinical research opportunities. </p><p style=\"LINE-HEIGHT: normal\">For more information on the registry see: <a href='http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm ' target='_blank'>http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm</a> </p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":791,"resourceId":1472,"resourceName":"GeneReview - Urea cycle disorders","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1217/' target='_blank'>GeneReviews</a> provides a current, expert-authored, peer-reviewed, full-text article urea cycle disorders in general that you may find helpful. GeneReview articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":792,"resourceId":1473,"resourceName":"MedlinePlus - Urea cycle disorders","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm ' target='_blank'>MedlinePlus.gov</a> provides more information on urea cycle disorders in general. MedlinePlus is a Web site designed by the National Library of Medicine to help you research your health questions.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":824,"resourceId":1544,"resourceName":"Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/HHH ' target='_blank'>Newborn Screening Coding and Terminology Guide</a> has information on the standard codes used for  newborn screening tests. Using these standards helps compare data across different laboratories. This resource was created by the National Library of Medicine.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0268540' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=415' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_HHHsyndrome-enPro770.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1846,"resourceId":3031,"resourceName":"Genetics Education Materials for School Success","descriptionText":"The <a href='http://www.gemssforschools.org/conditions/urea-cycle/default' target='_blank'>Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Education Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:238970' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":7837,"relatedDiseaseName":"Urea cycle disorders","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13236,"phenoTypeName":"Abnormal circulating citrulline concentration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1656,"phenoTypeName":"Hyperornithinemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9043,"phenoTypeName":"Neurodevelopmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8521,"phenoTypeName":"Abnormal pyramidal sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12145,"phenoTypeName":"Acute encephalopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13844,"phenoTypeName":"Clonus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14336,"phenoTypeName":"Episodic vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13239,"phenoTypeName":"Feeding difficulties","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2701,"phenoTypeName":"Hepatitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14292,"phenoTypeName":"Impaired vibratory sensation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14519,"phenoTypeName":"Oroticaciduria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11436,"phenoTypeName":"Poor coordination","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13460,"phenoTypeName":"Progressive cerebellar ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13396,"phenoTypeName":"Protein avoidance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8712,"phenoTypeName":"Spastic paraplegia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9417,"phenoTypeName":"Specific learning disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":305,"phenoTypeName":"Speech apraxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7889,"phenoTypeName":"Tachypnea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10945,"phenoTypeName":"Abnormality of the coagulation cascade","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13747,"phenoTypeName":"Generalized myoclonic seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13445,"phenoTypeName":"Multifocal cerebral white matter abnormalities","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13051,"phenoTypeName":"Respiratory alkalosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13452,"phenoTypeName":"Spastic gait","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5642,"phenoTypeName":"Chorioretinal atrophy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5551,"phenoTypeName":"Chorioretinal hypopigmentation","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5685,"phenoTypeName":"Hepatic failure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1118,"phenoTypeName":"Acute hepatitis","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5702,"phenoTypeName":"Decreased liver function","percentRanges":"-"},{"phenoTypeId":14146,"phenoTypeName":"Decreased nerve conduction velocity","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":9615,"phenoTypeName":"Hypopigmentation of the fundus","percentRanges":"-"},{"phenoTypeId":13450,"phenoTypeName":"Morphological abnormality of the pyramidal tract","percentRanges":"-"},{"phenoTypeId":3822,"phenoTypeName":"Psychomotor retardation","percentRanges":"-"},{"phenoTypeId":11407,"phenoTypeName":"Spastic paraparesis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Ornithine_translocase_deficiency_syndrome"}